6-K ·Filed Aug 11, 2026

GMAB

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001434265-26-000111
Actionable Insight • Neutral

This is a routine capital increase from employee warrant exercises with negligible dilution (0.04%). No trading action warranted; monitor for any upcoming pipeline catalysts or financial results.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
GMAB ▲ +7.10% at T+20d
NEUTRAL call ✓ call won +7.10% · α vs SPY +8.16% · entry $30.85 → $33.04
Next anchor: T+60d in 5w
Latest observation: T+35 +10.55% FF3 residual α
Entry anchored
Aug 11, 02:14 PM ET
via 1-min bar
T+1d
+1.85%
call +1.85% · α +1.60%
$31.42
settled 7w ago
T+5d
+6.84%
call +6.84% · α +7.24%
$32.96
settled 6w ago
T+20d
+7.10%
call +7.10% · α +8.16%
$33.04
settled 23d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Genmab filed a 6-K reporting a routine capital increase of 24,592 shares from employee warrant exercises, raising approximately DKK 37.9 million (0.04% of share capital). This is a standard administrative event with no material impact on the company's financial position or operations.

Key Facts

  • Share capital increased by 24,592 shares due to employee warrant exercises.
  • Proceeds to the company are approximately DKK 37.9 million.
  • The increase represents approximately 0.04% of Genmab's total share capital.
  • Total share capital post-increase is DKK 62,377,844 (62,377,844 shares).

Financial Impact

Proceeds of approximately DKK 37.9 million (0.04% of share capital) — immaterial.

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (GMAB) — Batch item 10001434265-26-000111
Document: gmab_20260811x6k.htm0001434265-26-000111
Document: 0001434265-26-000111-index-headers.html0001434265-26-000111
Document: 0001434265-26-000111-index.html0001434265-26-000111
Document: 0001434265-26-000111.txt0001434265-26-000111
6-K Filing (GMAB) — Batch item 60001434265-26-000111
Document: gmab_20260811x6k.htm0001434265-26-000111
Document: 0001434265-26-000111-index-headers.html0001434265-26-000111
Document: 0001434265-26-000111-index.html0001434265-26-000111
Document: 0001434265-26-000111.txt0001434265-26-000111
13 reports for GMAB
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +26.50%Jun 29, 2026
Filters
Rows
Reports for GMAB — sortable, filterable
TypeNow
Sep 8, 2026
24d ago
6-K
NEUTRAL ★ 2/10
$33.53 $32.65▼ −2.62%▼ −1.96%$34.75 (+3.64%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$31.42 $34.11▲ +8.56%▲ +9.01%$34.75 (+10.60%)
Aug 11, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$30.85 $32.96▲ +6.84%▲ +7.24%$34.75 (+12.64%)
Aug 6, 2026
8w ago
6-K
BULLISH ★ 6/10
$29.83 $31.34▲ +5.06%▲ +3.85%$34.75 (+16.49%)
Jul 15, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$29.08 $28.85▼ −0.79%▲ +0.19%$34.75 (+19.50%)
Jun 29, 2026
13w ago
6-K
BULLISH ★ 7/10
$27.47 $28.01▲ +1.97%▲ +1.36%$34.75 (+26.50%)
Jun 17, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$25.39 $25.87▲ +1.87%▲ +2.91%$34.75 (+36.86%)
Jun 16, 2026
15w ago
6-K
NEUTRAL ★ 1/10
$24.74 $25.94▲ +4.85%▲ +7.08%$34.75 (+40.46%)
Jun 15, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$24.58 $25.61▲ +4.19%▲ +5.57%$34.75 (+41.38%)
Jun 15, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$24.58 $25.61▲ +4.19%▲ +5.57%$34.75 (+41.38%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access